United States · Series B startup

Who invested in Allorion Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $50MMar 2023
Investors
2
See who backed them

The rounds

  1. Mar 2023
    Series B$50M

    Source recorded

Everyone who backed them

IDG CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Allorion Therapeutics

Who invested in Allorion Therapeutics?

Allorion Therapeutics's investors include Qiming Venture Partners and IDG Capital.

How much has Allorion Therapeutics raised?

Allorion Therapeutics has raised $50M across 1 round since 2023.

When did Allorion Therapeutics last raise?

Allorion Therapeutics's most recent round was a Series B of $50M in Mar 2023.

What was Allorion Therapeutics's biggest round?

Its most recent round, $50M in Mar 2023, is also its largest on record.

Who backed Allorion Therapeutics first?

Allorion Therapeutics's first round on record, in Mar 2023, was backed by Qiming Venture Partners and IDG Capital.

What stage is Allorion Therapeutics at?

Allorion Therapeutics's latest named round is a Series B, in Mar 2023.

Where is Allorion Therapeutics based?

Allorion Therapeutics is based in the United States.

Companies like Allorion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.